Global Health Headlines: Ebola, Pharmaceuticals, and Drug Regulations

Source Summary

The latest health news includes Biogen's cutback of Apellis programs after a $5.6 billion buyout, the U.S.'s Ebola Bundibugyo vaccine efforts, the FDA's proposed rule on foreign tobacco makers, and Congo's rising Ebola cases. Also covered are trade investigations, sterile fly plant inaugurations, and new pharmaceutical developments.